Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
- PMID: 11239454
- DOI: 10.1016/s1097-2765(01)00173-3
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
Abstract
Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and ionizing radiation. Although six FA genes (for subtypes A, C, D2, E, F, and G) have been cloned, their relationship to DNA repair remains unknown. In the current study, we show that a nuclear complex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FANCD2 protein to a monoubiquitinated isoform. In normal (non-FA) cells, FANCD2 is monoubiquitinated in response to DNA damage and is targeted to nuclear foci (dots). Activated FANCD2 protein colocalizes with the breast cancer susceptibility protein, BRCA1, in ionizing radiation-induced foci and in synaptonemal complexes of meiotic chromosomes. The FANCD2 protein, therefore, provides the missing link between the FA protein complex and the cellular BRCA1 repair machinery. Disruption of this pathway results in the cellular and clinical phenotype common to all FA subtypes.
Similar articles
-
Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.Exp Hematol. 2001 Dec;29(12):1448-55. doi: 10.1016/s0301-472x(01)00754-8. Exp Hematol. 2001. PMID: 11750104
-
The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.Carcinogenesis. 2001 Dec;22(12):1939-46. doi: 10.1093/carcin/22.12.1939. Carcinogenesis. 2001. PMID: 11751423
-
Molecular pathogenesis of fanconi anemia.Int J Hematol. 2002 Feb;75(2):123-8. doi: 10.1007/BF02982016. Int J Hematol. 2002. PMID: 11939257 Review.
-
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.Hum Mol Genet. 2002 Dec 1;11(25):3125-34. doi: 10.1093/hmg/11.25.3125. Hum Mol Genet. 2002. PMID: 12444097
-
Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.Int J Hematol. 2001 Jul;74(1):33-41. doi: 10.1007/BF02982547. Int J Hematol. 2001. PMID: 11530803 Review.
Cited by
-
Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy.Mol Cells. 2015 Aug;38(8):669-76. doi: 10.14348/molcells.2015.0175. Epub 2015 Jul 21. Mol Cells. 2015. PMID: 26194820 Free PMC article. Review.
-
Pathways for repairing and tolerating the spectrum of oxidative DNA lesions.Cancer Lett. 2012 Dec 31;327(1-2):61-72. doi: 10.1016/j.canlet.2012.02.001. Epub 2012 Feb 19. Cancer Lett. 2012. PMID: 22353689 Free PMC article. Review.
-
CtIP is required to initiate replication-dependent interstrand crosslink repair.PLoS Genet. 2012;8(11):e1003050. doi: 10.1371/journal.pgen.1003050. Epub 2012 Nov 8. PLoS Genet. 2012. PMID: 23144634 Free PMC article.
-
FANCD2 activates transcription of TAp63 and suppresses tumorigenesis.Mol Cell. 2013 Jun 27;50(6):908-18. doi: 10.1016/j.molcel.2013.05.017. Mol Cell. 2013. PMID: 23806336 Free PMC article.
-
The PTEN phosphatase functions cooperatively with the Fanconi anemia proteins in DNA crosslink repair.Sci Rep. 2016 Nov 7;6:36439. doi: 10.1038/srep36439. Sci Rep. 2016. PMID: 27819275 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
